Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe history shows a new revision entry v3.6.5 added, replacing the previous v3.6.4, indicating a minor update to the record's revision history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision v3.6.4 was added to the study's history, replacing the previous v3.6.3 and signaling a small update to the record-keeping for this study.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry v3.6.3 was added to the study history, and the previous revision v3.6.2 was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedThe record history shows a new revision tag v3.6.2, replacing v3.6.0. It indicates a page-level update rather than substantive changes to study data.SummaryDifference0.1%

- Check65 days agoChange DetectedRecruitment is closed (no longer looking for participants), indicating enrollment has ended. The history also shows a new page revision to v3.6.0, with the prior v3.5.5 entry removed.SummaryDifference0.5%

- Check72 days agoChange DetectedA new revision tag, v3.5.5, was added to the Record History, signaling a newer version of the page.SummaryDifference0.1%

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.